Related Articles
Functional expression of TLR9 in esophageal cancer
Chloroquine has tumor‑inhibitory and tumor‑promoting effects in triple‑negative breast cancer
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer
Chloroquine inhibits MGC803 gastric cancer cell migration via the Toll-like receptor 9/nuclear factor kappa B signaling pathway
Experimental therapy for colon cancer: Anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53